These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20799727)

  • 1. NMR characterization of copper-binding domains 4-6 of ATP7B .
    Fatemi N; Korzhnev DM; Velyvis A; Sarkar B; Forman-Kay JD
    Biochemistry; 2010 Oct; 49(39):8468-77. PubMed ID: 20799727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational dynamics of metal-binding domains in Wilson disease protein: molecular insights into selective copper transfer.
    Rodriguez-Granillo A; Crespo A; Wittung-Stafshede P
    Biochemistry; 2009 Jun; 48(25):5849-63. PubMed ID: 19449859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper transfer to the N-terminal domain of the Wilson disease protein (ATP7B): X-ray absorption spectroscopy of reconstituted and chaperone-loaded metal binding domains and their interaction with exogenous ligands.
    Ralle M; Lutsenko S; Blackburn NJ
    J Inorg Biochem; 2004 May; 98(5):765-74. PubMed ID: 15134922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1.
    Banci L; Bertini I; Cantini F; Rosenzweig AC; Yatsunyk LA
    Biochemistry; 2008 Jul; 47(28):7423-9. PubMed ID: 18558714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics.
    Yu CH; Yang N; Bothe J; Tonelli M; Nokhrin S; Dolgova NV; Braiterman L; Lutsenko S; Dmitriev OY
    J Biol Chem; 2017 Nov; 292(44):18169-18177. PubMed ID: 28900031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.
    Lutsenko S; Tsivkovskii R; Walker JM
    Ann N Y Acad Sci; 2003 Apr; 986():204-11. PubMed ID: 12763797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1.
    Banci L; Bertini I; Cantini F; Massagni C; Migliardi M; Rosato A
    J Biol Chem; 2009 Apr; 284(14):9354-60. PubMed ID: 19181666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake.
    Achila D; Banci L; Bertini I; Bunce J; Ciofi-Baffoni S; Huffman DL
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5729-34. PubMed ID: 16571664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics and stability of the metal binding domains of the Menkes ATPase and their interaction with metallochaperone HAH1.
    Arumugam K; Crouzy S
    Biochemistry; 2012 Nov; 51(44):8885-906. PubMed ID: 23075277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of copper(I) by the Wilson disease protein and its copper chaperone.
    Wernimont AK; Yatsunyk LA; Rosenzweig AC
    J Biol Chem; 2004 Mar; 279(13):12269-76. PubMed ID: 14709553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity.
    Walker JM; Tsivkovskii R; Lutsenko S
    J Biol Chem; 2002 Aug; 277(31):27953-9. PubMed ID: 12029094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cu(I) binding and transfer by the N terminus of the Wilson disease protein.
    Yatsunyk LA; Rosenzweig AC
    J Biol Chem; 2007 Mar; 282(12):8622-31. PubMed ID: 17229731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An NMR study of the interaction between the human copper(I) chaperone and the second and fifth metal-binding domains of the Menkes protein.
    Banci L; Bertini I; Ciofi-Baffoni S; Chasapis CT; Hadjiliadis N; Rosato A
    FEBS J; 2005 Feb; 272(3):865-71. PubMed ID: 15670166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
    de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
    Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical basis of regulation of human copper-transporting ATPases.
    Lutsenko S; LeShane ES; Shinde U
    Arch Biochem Biophys; 2007 Jul; 463(2):134-48. PubMed ID: 17562324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved residues modulate copper release in human copper chaperone Atox1.
    Hussain F; Olson JS; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11158-63. PubMed ID: 18685091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the interaction of the copper chaperone Atox1 with the metal binding sites of the Menkes protein.
    Strausak D; Howie MK; Firth SD; Schlicksupp A; Pipkorn R; Multhaup G; Mercer JF
    J Biol Chem; 2003 Jun; 278(23):20821-7. PubMed ID: 12679332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR backbone resonance assignments of the N, P domains of CopA, a copper-transporting ATPase, in the apo and ligand bound states.
    Meng D; Bruschweiler-Li L; Zhang F; Brüschweiler R
    Biomol NMR Assign; 2015 Apr; 9(1):129-33. PubMed ID: 24706033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between metal-binding domains modulate intracellular targeting of Cu(I)-ATPase ATP7B, as revealed by nanobody binding.
    Huang Y; Nokhrin S; Hassanzadeh-Ghassabeh G; Yu CH; Yang H; Barry AN; Tonelli M; Markley JL; Muyldermans S; Dmitriev OY; Lutsenko S
    J Biol Chem; 2014 Nov; 289(47):32682-93. PubMed ID: 25253690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.
    Dmitriev O; Tsivkovskii R; Abildgaard F; Morgan CT; Markley JL; Lutsenko S
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5302-7. PubMed ID: 16567646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.